BASF

Abstract Background: Hypertension exhibits marked circadian variations, with an increased risk of cardiovascular events during the early morning hours. Conventional...

Abstract Poor aqueous solubility limits the in vitro dissolution performance of many drugs, among them curcumin which is a bioactive...

Abstract Background: Lipid nanoparticles are widely investigated as oral drug delivery systems, but their intestinal performance remains difficult to predict based...

This year CPHI Europe opens its doors in Milan at Fiera Milano. From 6th to 8th October you can have a...

Abstract Lactose (LA), the primary carrier in dry powder inhalers (DPIs), often exhibits excessive drug adhesion, which impairs aerosolization. In...

Abstract This study investigates how the particle size range (PSR) of the polymeric component in a powder mixture affects the...

Abstract In the pediatric patient group, there is a constant need for individualized dosage forms with precise and adjustable drug...

Compare formulations. Analyze costs. Decide with confidence. With the “Production Cost Calculation & Comparison” app in ZoomLab®*, users can calculate...

Abstract Despite various attempts at solubility enhancement and advances in formulation technologies, improving the bioavailability of poorly water-soluble compounds remains...

Formulation of poorly soluble APIs remains one of the most persistent challenges in modern pharmaceutical development. With a growing number...